Articles from BIOTECH Patent News (October 1, 1998)

Title	Author	Type	Words
Abgenix and Millennium form inflammatory disease collaboration.			555
Alexion issued key xenotransplantation gene patent.			506
Amersham Pharmacia Biotech extends patent action to include Celera Amersham Pharmacia Biotech (London, United Kingdom; +44-1222-526-000), the joint-venture organization owned by Nycomed Amersham plc (London, United Kingdom; +44-1494-542-051) and Pharmacia & Upjohn (Branchburg, NJ)(1997 revenue - $7.0 billion), has extended its intellectual property action on energy transfer dyes against Perkin-Elmer Corporation (Norwalk, CT; 203-762-1000)(1997 revenue - $1.3 billion).			396
Avitech obtains United States patent.			52
Biogen opposes Rentschler's European beta interferon patent.			201
Bionx implants announces the commencement of two patent infringement lawsuits.			115
Boehringer Mannheim applies for patent.			39
Boston Biomedica acquires BioSeq.			898
Cell Genesys to receive broad European patent for gene activation technology.			547
Centocor obtains United States patent.			46
Coulter obtains United States patent.			87
Creative Biomolecules applies for patent.			46
Eco Soil announces acquisition of license and patent rights from Mycogen.			365
Eisai applies for patent.			44
Genetic Information Research Institute obtains United States patent.			66
Genome Therapeutics sequence Enterobacter cloacae and Acinetobacter baumannii.			665
Got-A-Gene obtains United States patent.			81
Hawaii Biotechnology Group obtains United States patent.			38
ImmuLogic obtains United States patent.			58
Immunomedics invents vaccine technology for cancer and infectious diseases.			366
Infectech obtains United States patent.			54
Institut Pasteur obtains United States patent.			38
Integris Baptist Medical Center obtains United States patent.			53
La Jolla Pharmaceutical identifies protein region for life-threatening blood clotting disorder.			532
Leuven Research & Development obtains United States patent.			35
Magainin applies for patent.			38
Merck applies for patent.			43
Microbiological Research Authority obtains United States patent.			78
Mochida obtains United States patent.			30
NeoTherapeutics announces issuance of new patent on treatment of neurodegenerative diseases with neurotrophic factors.			515
OmegaTech obtains United States patent.			54
Onyx obtains United States patent.			56
Patent issues to Visible Genetics for combination HIV viral load and genotyping test.			400
Pharmacia & Upjohn applies for patent.			40
Purdue University applies for patent.			43
Rutgers University obtains United States patent.			44
SIBIA Neurosciences announces issuance of United States patents.			360
Targeted Genetics applies for patent.			47
Thomas Jefferson University applies for patent.			48
Tularik obtains United States patent.			49
University of Amsterdam applies for patent.			38
University of California obtains United States patent.			93
University of Leeds applies for patent.			46
University of Massachusetts applies for patent.			38
Yeda Research & Development Co. obtains United States patent.			41